Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (990)	1/25/1998 2:08:00 PM
From: HumbleHarv	Read Replies (1) \| Respond to of 1359

How long do you suspect it will it be before the FDA meets to decide whether or not to approve CerAxon/citicoline? IF they do approve this drug, will investors finally recognize that there is more to IPIC than just the Redux story. I brought this stock on DLJ's recommendation when the stock hit 16. However, ever since the stock has gone south. I would be quite content if the stock merely went back up to 16. Could that possibly occur with the approval of this new drug, or will it also take some resolution of the Redux issue?